Furukawa et al. (2017) described oxidative stress as one of the main factors involved in obesity-related morbidity, and Nrf2 seems to be a promising new target to treat obesity [134]. Here, NFE2L2 is linked to obesity due to melanocortin 4 receptor deficiency.